- Medical - Diagnostics & Research
- Healthcare
Quest Diagnostics Incorporated
DGX · US ·
NYSE
150.77
USD
+0.35
(0.23%)
-
7.56
EPS
-
19.95
P/E
-
16.8B
MARKET CAP
-
1.94%
DIV YIELD
Executives
Name | Title | Pay |
---|---|---|
Mr. Gary D. Samuels | Senior Vice President & Chief Communications Officer | -- |
Mr. Shawn C. Bevec | Vice President of Investor Relations | -- |
Ms. Kristin Lee Wallace Esq. | Senior Vice President & Chief Compliance Officer | -- |
Ms. Catherine T. Doherty | Executive Vice President of Regional Businesses | 1M |
Mr. Karthik Kuppusamy Ph.D. | Senior Vice President of Clinical Solutions | 840K |
Mr. James E. Davis | Chairman, Chief Executive Officer & President | 2.88M |
Mr. Michael E. Prevoznik | Senior Vice President & General Counsel | 881K |
Mr. Michael J. Deppe | Senior Vice President, Corporate Controller & Chief Accounting Officer | -- |
Mr. Murali Balakumar | Senior Vice President, Chief Information & Digital Officer | -- |
Mr. Sam A. Samad | Executive Vice President & Chief Financial Officer | 1.33M |
Insider Transactions
Date | Name | Title | Acquisition Or Disposition | Stock / Options | # of Shares | Price |
---|---|---|---|---|---|---|
2024-07-22 | DELANEY MARK E | SVP & Chief Commercial Officer | A - L-Small | Common Stock | 6 | 146.984 |
2024-07-24 | DELANEY MARK E | SVP & Chief Commercial Officer | D - S-Sale | Common Stock | 420 | 143.08 |
2024-07-22 | SAMAD SAM | Executive Vice President & CFO | A - L-Small | Common Stock | 21 | 146.974 |
2024-07-22 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A - L-Small | Common Stock | 31 | 146.973 |
2024-07-22 | Plewman Patrick | SVP for Diagnostic Services | A - L-Small | Common Stock | 60 | 146.974 |
2024-07-22 | Gregg Vicky B | director | A - L-Small | Common Stock | 77 | 146.973 |
2024-07-16 | SAMAD SAM | Executive Vice President & CFO | D - F-InKind | Common Stock | 3910 | 142.65 |
2024-07-01 | RING TIMOTHY M | director | A - A-Award | Phantom Stock Units | 308 | 0 |
2024-05-16 | CARTER ROBERT B | director | A - A-Award | Common Stock | 1482 | 0 |
2024-05-16 | PFEIFFER GARY M | director | A - A-Award | Common Stock | 1482 | 0 |
2024-05-16 | RING TIMOTHY M | director | A - A-Award | Common Stock | 1482 | 0 |
2024-05-16 | MAIN TIMOTHY L | director | A - A-Award | Common Stock | 1482 | 0 |
2024-05-16 | Gregg Vicky B | director | A - A-Award | Common Stock | 1482 | 0 |
2024-05-16 | Lassiter Wright III | director | A - A-Award | Common Stock | 1482 | 0 |
2024-05-16 | MORRISON DENISE M | director | A - A-Award | Common Stock | 1482 | 0 |
2024-05-16 | Doi Tracey | director | A - A-Award | Common Stock | 1482 | 0 |
2024-05-16 | Diaz Luis | director | A - A-Award | Common Stock | 1482 | 0 |
2024-05-16 | CARTER ROBERT B | - | 0 | 0 | ||
2024-04-29 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | D - S-Sale | Common Stock | 1760 | 140 |
2024-04-22 | Gregg Vicky B | director | A - A-Award | Common Stock | 81 | 126.244 |
2024-04-22 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A - A-Award | Common Stock | 45 | 126.246 |
2024-04-22 | Plewman Patrick | SVP for Diagnostic Services | A - A-Award | Common Stock | 69 | 126.245 |
2024-04-22 | SAMAD SAM | Executive Vice President & CFO | A - A-Award | Common Stock | 24 | 126.245 |
2024-04-01 | RING TIMOTHY M | director | A - A-Award | Phantom Stock Units | 311 | 0 |
2024-03-26 | DELANEY MARK E | SVP & Chief Commercial Officer | D - F-InKind | Common Stock | 170 | 128.11 |
2024-03-26 | Plewman Patrick | SVP for Diagnostic Services | D - F-InKind | Common Stock | 114 | 128.11 |
2024-02-28 | Plewman Patrick | SVP for Diagnostic Services | D - F-InKind | Common Stock | 228 | 126.36 |
2024-02-28 | Plewman Patrick | SVP for Diagnostic Services | D - F-InKind | Common Stock | 105 | 126.36 |
2024-02-28 | Doherty Catherine T. | EVP, Regional Businesses | D - F-InKind | Common Stock | 644 | 126.36 |
2024-02-28 | Doherty Catherine T. | EVP, Regional Businesses | D - F-InKind | Common Stock | 557 | 126.36 |
2024-02-28 | Doherty Catherine T. | EVP, Regional Businesses | D - S-Sale | Common Stock | 5557 | 126.57 |
2024-02-29 | Doherty Catherine T. | EVP, Regional Businesses | D - S-Sale | Common Stock | 1187 | 125.88 |
2024-02-28 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - F-InKind | Common Stock | 405 | 126.36 |
2024-02-28 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - F-InKind | Common Stock | 456 | 126.36 |
2024-02-29 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - S-Sale | Common Stock | 5611 | 125.88 |
2024-02-28 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | D - F-InKind | Common Stock | 205 | 126.36 |
2024-02-28 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | D - F-InKind | Common Stock | 68 | 126.36 |
2024-02-28 | SAMAD SAM | Executive Vice President & CFO | D - F-InKind | Common Stock | 656 | 126.36 |
2024-02-28 | Davis J. E. | CEO and President | D - F-InKind | Common Stock | 3216 | 126.36 |
2024-02-28 | Davis J. E. | CEO and President | D - F-InKind | Common Stock | 1804 | 126.36 |
2024-02-28 | GARDNER MARK A | SVP of Molecular Gen & Oncol | D - F-InKind | Common Stock | 262 | 126.36 |
2024-02-28 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | D - F-InKind | Common Stock | 52 | 126.36 |
2024-02-28 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | D - F-InKind | Common Stock | 57 | 126.36 |
2024-02-28 | DELANEY MARK E | SVP & Chief Commercial Officer | D - F-InKind | Common Stock | 225 | 126.36 |
2024-02-23 | Davis J. E. | CEO and President | A - A-Award | Common Stock | 13390 | 125.02 |
2024-02-23 | Davis J. E. | CEO and President | D - F-InKind | Common Stock | 6525 | 125.02 |
2024-02-23 | PREVOZNIK MICHAEL E | SVP & General Counsel | A - A-Award | Common Stock | 7569 | 125.02 |
2024-02-23 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - F-InKind | Common Stock | 2825 | 125.02 |
2024-02-23 | Plewman Patrick | SVP for Diagnostic Services | A - A-Award | Common Stock | 2388 | 125.02 |
2024-02-23 | Plewman Patrick | SVP for Diagnostic Services | D - F-InKind | Common Stock | 869 | 125.02 |
2024-02-23 | Doherty Catherine T. | EVP, Regional Businesses | A - A-Award | Common Stock | 9314 | 125.02 |
2024-02-23 | Doherty Catherine T. | EVP, Regional Businesses | D - F-InKind | Common Stock | 3757 | 125.02 |
2024-02-23 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A - A-Award | Common Stock | 2039 | 125.02 |
2024-02-23 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | D - F-InKind | Common Stock | 619 | 125.02 |
2024-02-23 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | A - A-Award | Common Stock | 1689 | 125.02 |
2024-02-23 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | D - F-InKind | Common Stock | 631 | 125.02 |
2024-02-21 | Plewman Patrick | SVP for Diagnostic Services | D - F-InKind | Common Stock | 139 | 125.02 |
2024-02-21 | Davis J. E. | CEO and President | D - F-InKind | Common Stock | 762 | 125.02 |
2024-02-21 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - F-InKind | Common Stock | 407 | 125.02 |
2024-02-22 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - S-Sale | Common Stock | 661 | 126.14 |
2024-02-23 | Gregg Vicky B | director | D - S-Sale | Common Stock | 2500 | 126.6386 |
2024-02-21 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | D - F-InKind | Common Stock | 102 | 125.02 |
2024-02-21 | Doherty Catherine T. | EVP, Regional Businesses | D - F-InKind | Common Stock | 493 | 125.02 |
2024-02-22 | Doherty Catherine T. | EVP, Regional Businesses | D - S-Sale | Common Stock | 821 | 126.14 |
2024-02-21 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | D - F-InKind | Common Stock | 89 | 125.02 |
2024-02-14 | Davis J. E. | CEO and President | A - A-Award | Common Stock | 22251 | 0 |
2024-02-14 | Davis J. E. | CEO and President | A - A-Award | Non-Qualifed Stock Option (right to buy) | 92779 | 127.805 |
2024-02-14 | GARDNER MARK A | SVP of Molecular Gen & Oncol | A - A-Award | Non-Qualifed Stock Option (right to buy) | 9376 | 127.805 |
2024-02-14 | GARDNER MARK A | SVP of Molecular Gen & Oncol | A - A-Award | Common Stock | 2250 | 0 |
2024-02-14 | Plewman Patrick | SVP for Diagnostic Services | A - A-Award | Common Stock | 2446 | 0 |
2024-02-14 | Plewman Patrick | SVP for Diagnostic Services | A - A-Award | Non-Qualifed Stock Option (right to buy) | 10190 | 127.805 |
2024-02-14 | PREVOZNIK MICHAEL E | SVP & General Counsel | A - A-Award | Common Stock | 2935 | 0 |
2024-02-14 | PREVOZNIK MICHAEL E | SVP & General Counsel | A - A-Award | Non-Qualifed Stock Option (right to buy) | 12231 | 127.805 |
2024-02-14 | SAMAD SAM | Executive Vice President & CFO | A - A-Award | Non-Qualifed Stock Option (right to buy) | 22835 | 127.805 |
2024-02-14 | SAMAD SAM | Executive Vice President & CFO | A - A-Award | Common Stock | 5478 | 0 |
2024-02-14 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A - A-Award | Common Stock | 2641 | 0 |
2024-02-14 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A - A-Award | Non-Qualifed Stock Option (right to buy) | 11007 | 127.805 |
2024-02-14 | DELANEY MARK E | SVP & Chief Commercial Officer | A - A-Award | Non-Qualifed Stock Option (right to buy) | 9783 | 127.805 |
2024-02-14 | DELANEY MARK E | SVP & Chief Commercial Officer | A - A-Award | Common Stock | 2348 | 0 |
2024-02-14 | Doherty Catherine T. | SVP, Regional Businesses | A - A-Award | Common Stock | 4304 | 0 |
2024-02-14 | Doherty Catherine T. | SVP, Regional Businesses | A - A-Award | Non-Qualifed Stock Option (right to buy) | 17939 | 127.805 |
2024-02-14 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | A - A-Award | Common Stock | 558 | 0 |
2024-02-14 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | A - A-Award | Non-Qualifed Stock Option (right to buy) | 2322 | 127.805 |
2024-01-31 | Gregg Vicky B | director | A - A-Award | Common Stock | 88 | 129.327 |
2024-01-31 | SAMAD SAM | Executive Vice President & CFO | A - A-Award | Common Stock | 17 | 129.327 |
2024-01-31 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A - A-Award | Common Stock | 29 | 129.326 |
2024-01-31 | Plewman Patrick | SVP for Diagnostic Services | A - A-Award | Common Stock | 50 | 129.326 |
2023-12-31 | PREVOZNIK MICHAEL E | SVP & General Counsel | I - | Common Stock | 0 | 0 |
2024-01-02 | RING TIMOTHY M | director | A - A-Award | Phantom Stock Units | 294 | 0 |
2023-10-23 | Gregg Vicky B | director | A - A-Award | Common Stock | 92 | 122.863 |
2023-10-23 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A - A-Award | Common Stock | 30 | 122.862 |
2023-10-23 | Plewman Patrick | SVP for Diagnostic Services | A - A-Award | Common Stock | 52 | 122.836 |
2023-10-23 | SAMAD SAM | Executive Vice President & CFO | A - A-Award | Common Stock | 18 | 122.864 |
2023-10-02 | RING TIMOTHY M | director | A - A-Award | Phantom Stock Units | 344 | 0 |
2023-09-25 | GARDNER MARK A | SVP of Molecular Gen & Oncol | D - F-InKind | Common Stock | 116 | 126.22 |
2023-08-15 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | D - F-InKind | Common Stock | 74 | 135.23 |
2023-07-25 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A - A-Award | Common Stock | 25 | 144.592 |
2023-07-25 | Gregg Vicky B | director | A - A-Award | Common Stock | 78 | 144.591 |
2023-07-25 | Plewman Patrick | SVP for Diagnostic Services | A - A-Award | Common Stock | 44 | 144.592 |
2023-07-14 | SAMAD SAM | Executive Vice President & CFO | D - F-InKind | Common Stock | 3909 | 140.18 |
2023-07-03 | RING TIMOTHY M | director | A - A-Award | Phantom Stock Units | 297 | 0 |
2023-05-17 | Diaz Luis | director | A - A-Award | Common Stock | 1369 | 0 |
2023-05-17 | Gregg Vicky B | director | A - A-Award | Common Stock | 1369 | 0 |
2023-05-17 | RING TIMOTHY M | director | A - A-Award | Common Stock | 1369 | 0 |
2023-05-17 | Lassiter Wright III | director | A - A-Award | Common Stock | 1369 | 0 |
2023-05-17 | Doi Tracey | director | A - A-Award | Common Stock | 1369 | 0 |
2023-05-17 | PFEIFFER GARY M | director | A - A-Award | Common Stock | 1369 | 0 |
2023-05-17 | WILENSKY GAIL R | director | A - A-Award | Common Stock | 1369 | 0 |
2023-05-17 | Diaz Luis | - | 0 | 0 | ||
2023-05-17 | MORRISON DENISE M | director | A - A-Award | Common Stock | 1369 | 0 |
2023-05-17 | MAIN TIMOTHY L | director | A - A-Award | Common Stock | 1369 | 0 |
2023-04-24 | Plewman Patrick | SVP for Diagnostic Services | A - L-Small | Common Stock | 44 | 143.082 |
2023-04-24 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A - L-Small | Common Stock | 25 | 143.079 |
2023-04-24 | Gregg Vicky B | director | A - L-Small | Common Stock | 72 | 143.081 |
2023-04-03 | RING TIMOTHY M | director | A - A-Award | Phantom Stock Units | 291 | 0 |
2023-03-24 | Plewman Patrick | SVP for Diagnostic Services | D - F-InKind | Common Stock | 99 | 134.25 |
2023-03-24 | DELANEY MARK E | SVP & Chief Commercial Officer | D - F-InKind | Common Stock | 170 | 134.25 |
2023-03-06 | PREVOZNIK MICHAEL E | SVP & General Counsel | A - A-Award | Common Stock | 8595 | 147.86 |
2023-03-06 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - F-InKind | Common Stock | 3841 | 147.86 |
2023-03-07 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - S-Sale | Common Stock | 4754 | 140.55 |
2023-03-06 | Doherty Catherine T. | SVP, Regional Businesses | A - A-Award | Common Stock | 9917 | 147.86 |
2023-03-06 | Doherty Catherine T. | SVP, Regional Businesses | D - F-InKind | Common Stock | 4610 | 147.86 |
2023-03-07 | Doherty Catherine T. | SVP, Regional Businesses | D - S-Sale | Common Stock | 5307 | 140.55 |
2023-03-06 | Plewman Patrick | SVP for Diagnostic Services | A - A-Award | Common Stock | 2579 | 147.86 |
2023-03-06 | Plewman Patrick | SVP for Diagnostic Services | D - F-InKind | Common Stock | 799 | 147.86 |
2023-03-06 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | A - A-Award | Common Stock | 1918 | 147.86 |
2023-03-06 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | D - F-InKind | Common Stock | 682 | 147.86 |
2023-03-06 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A - A-Award | Common Stock | 1985 | 147.86 |
2023-03-06 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | D - F-InKind | Common Stock | 583 | 147.86 |
2023-03-06 | Davis J. E. | CEO and President | A - A-Award | Common Stock | 15204 | 147.86 |
2023-03-06 | Davis J. E. | CEO and President | D - F-InKind | Common Stock | 8036 | 147.86 |
2023-03-06 | RUSCKOWSKI STEPHEN H | director | A - A-Award | Common Stock | 82631 | 147.86 |
2023-03-06 | RUSCKOWSKI STEPHEN H | director | D - F-InKind | Common Stock | 38604 | 147.86 |
2023-03-03 | Doherty Catherine T. | SVP, Regional Businesses | D - S-Sale | Common Stock | 717 | 140.63 |
2023-03-01 | RUSCKOWSKI STEPHEN H | director | D - F-InKind | Common Stock | 3496 | 140.69 |
2023-03-01 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - F-InKind | Common Stock | 320 | 140.69 |
2023-03-02 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - S-Sale | Common Stock | 593 | 138.54 |
2023-03-01 | Plewman Patrick | SVP for Diagnostic Services | D - F-InKind | Common Stock | 90 | 140.69 |
2023-03-01 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | D - F-InKind | Common Stock | 68 | 140.69 |
2023-03-01 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | D - F-InKind | Common Stock | 65 | 140.69 |
2023-03-01 | Doherty Catherine T. | SVP, Regional Businesses | D - F-InKind | Common Stock | 392 | 140.69 |
2023-02-23 | Davis J. E. | CEO and President | A - A-Award | Common Stock | 17443 | 0 |
2023-02-23 | Davis J. E. | CEO and President | D - F-InKind | Common Stock | 1473 | 147.86 |
2023-02-23 | Davis J. E. | CEO and President | A - A-Award | Non-Qualifed Stock Option (right to buy) | 68956 | 143.33 |
2023-02-23 | RUSCKOWSKI STEPHEN H | director | A - A-Award | Common Stock | 20059 | 0 |
2023-02-23 | RUSCKOWSKI STEPHEN H | director | D - F-InKind | Common Stock | 5826 | 147.86 |
2023-02-23 | SAMAD SAM | Executive Vice President & CFO | A - A-Award | Common Stock | 4710 | 0 |
2023-02-23 | SAMAD SAM | Executive Vice President & CFO | A - A-Award | Non-Qualifed Stock Option (right to buy) | 18616 | 143.33 |
2023-02-23 | PREVOZNIK MICHAEL E | SVP & General Counsel | A - A-Award | Common Stock | 2442 | 0 |
2023-02-24 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - S-Sale | Common Stock | 1415 | 141.42 |
2023-02-23 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - F-InKind | Common Stock | 811 | 147.86 |
2023-02-23 | PREVOZNIK MICHAEL E | SVP & General Counsel | A - A-Award | Non-Qualifed Stock Option (right to buy) | 9653 | 143.33 |
2023-02-23 | Plewman Patrick | SVP for Diagnostic Services | A - A-Award | Common Stock | 1919 | 0 |
2023-02-23 | Plewman Patrick | SVP for Diagnostic Services | D - F-InKind | Common Stock | 245 | 147.86 |
2023-02-23 | Plewman Patrick | SVP for Diagnostic Services | A - A-Award | Non-Qualifed Stock Option (right to buy) | 7584 | 143.33 |
2023-02-23 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | A - A-Award | Common Stock | 498 | 0 |
2023-02-23 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | D - F-InKind | Common Stock | 188 | 147.86 |
2023-02-23 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | A - A-Award | Non-Qualifed Stock Option (right to buy) | 1960 | 143.33 |
2023-02-23 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A - A-Award | Common Stock | 2094 | 0 |
2023-02-23 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A - A-Award | Non-Qualifed Stock Option (right to buy) | 8270 | 143.33 |
2023-02-23 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | D - F-InKind | Common Stock | 195 | 147.86 |
2023-02-23 | GARDNER MARK A | SVP of Molecular Gen & Oncol | A - A-Award | Non-Qualifed Stock Option (right to buy) | 7584 | 143.33 |
2023-02-23 | GARDNER MARK A | SVP of Molecular Gen & Oncol | A - A-Award | Common Stock | 1919 | 0 |
2023-02-23 | Doherty Catherine T. | SVP, Regional Businesses | A - A-Award | Common Stock | 3838 | 0 |
2023-02-24 | Doherty Catherine T. | SVP, Regional Businesses | D - S-Sale | Common Stock | 1690 | 141.42 |
2023-02-23 | Doherty Catherine T. | SVP, Regional Businesses | D - F-InKind | Common Stock | 962 | 147.86 |
2023-02-27 | Doherty Catherine T. | SVP, Regional Businesses | A - A-Award | Non-Qualifed Stock Option (right to buy) | 15167 | 143.33 |
2023-02-23 | DELANEY MARK E | SVP & Chief Commercial Officer | A - A-Award | Non-Qualifed Stock Option (right to buy) | 7584 | 143.33 |
2023-02-23 | DELANEY MARK E | SVP & Chief Commercial Officer | A - A-Award | Common Stock | 1919 | 0 |
2022-11-16 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | D - | Common Stock | 0 | 0 |
2022-11-16 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | I - | Common Stock | 0 | 0 |
2022-11-16 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | I - | Common Stock | 0 | 0 |
2022-11-16 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | D - | Non-Qualifed Stock Option (right to buy) | 3045 | 86.63 |
2022-11-16 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | D - | Non-Qualifed Stock Option (right to buy) | 5224 | 112.17 |
2022-11-16 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | D - | Non-Qualifed Stock Option (right to buy) | 4827 | 121.805 |
2022-11-16 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | D - | Non-Qualifed Stock Option (right to buy) | 3320 | 127.725 |
2022-11-16 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | D - | Non-Qualifed Stock Option (right to buy) | 3212 | 140.39 |
2023-02-01 | Gregg Vicky B | director | A - L-Small | Common Stock | 64 | 146.746 |
2023-02-01 | Plewman Patrick | SVP for Diagnostic Services | A - L-Small | Common Stock | 27 | 146.746 |
2023-02-01 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A - L-Small | Common Stock | 13 | 146.746 |
2023-01-03 | RING TIMOTHY M | director | A - A-Award | Phantom Stock Units | 267 | 0 |
2022-12-01 | RING TIMOTHY M | director | A - M-Exempt | Common Stock | 1053 | 53.125 |
2022-12-01 | RING TIMOTHY M | director | A - M-Exempt | Common Stock | 972 | 62.01 |
2022-12-01 | RING TIMOTHY M | director | D - S-Sale | Common Stock | 2025 | 152.5 |
2022-12-01 | RING TIMOTHY M | director | D - M-Exempt | Stock Options (Right to Buy) | 1053 | 53.125 |
2022-11-28 | Doherty Catherine T. | SVP, Regional Businesses | A - M-Exempt | Common Stock | 40765 | 86.63 |
2022-11-28 | Doherty Catherine T. | SVP, Regional Businesses | D - S-Sale | Common Stock | 17358 | 148.9153 |
2022-11-28 | Doherty Catherine T. | SVP, Regional Businesses | D - S-Sale | Common Stock | 23407 | 149.3737 |
2022-11-28 | Doherty Catherine T. | SVP, Regional Businesses | D - M-Exempt | Non-Qualifed Stock Option (right to buy) | 40765 | 86.63 |
2022-11-16 | Plewman Patrick | SVP for Diagnostic Services | D - | Non-Qualifed Stock Option (right to buy) | 4274 | 127.725 |
2022-11-16 | Plewman Patrick | SVP for Diagnostic Services | D - | Common Stock | 0 | 0 |
2022-11-16 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | D - | Non-Qualifed Stock Option (right to buy) | 3212 | 140.39 |
2022-11-16 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | D - | Common Stock | 0 | 0 |
2022-11-16 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | I - | 401(k) | 0 | 0 |
2022-11-16 | GARDNER MARK A | SVP of Molecular Gen & Oncol | D - | Non-Qualifed Stock Option (right to buy) | 3941 | 124.845 |
2022-11-16 | GARDNER MARK A | SVP of Molecular Gen & Oncol | D - | Common Stock | 0 | 0 |
2022-11-16 | DELANEY MARK E | SVP & Chief Commercial Officer | D - | Non-Qualifed Stock Option (right to buy) | 7846 | 144.47 |
2022-11-16 | DELANEY MARK E | SVP & Chief Commercial Officer | D - | Common Stock | 0 | 0 |
2022-11-01 | Davis J. E. | CEO and President | A - A-Award | Common Stock | 13980 | 0 |
2022-11-01 | RING TIMOTHY M | director | A - M-Exempt | Common Stock | 369 | 62.01 |
2022-11-01 | RING TIMOTHY M | director | A - M-Exempt | Common Stock | 1371 | 60.785 |
2022-11-01 | RING TIMOTHY M | director | A - M-Exempt | Common Stock | 260 | 61.225 |
2022-11-01 | RING TIMOTHY M | director | D - S-Sale | Common Stock | 2000 | 144.06 |
2022-11-01 | RING TIMOTHY M | director | D - M-Exempt | Stock Options (Right to Buy) | 369 | 62.01 |
2022-11-01 | RING TIMOTHY M | director | D - M-Exempt | Stock Options (Right to Buy) | 1371 | 60.785 |
2022-10-26 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | A - M-Exempt | Common Stock | 6371 | 56.12 |
2022-10-26 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | A - M-Exempt | Common Stock | 9126 | 52.165 |
2022-10-26 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | D - S-Sale | Common Stock | 15497 | 145 |
2022-10-26 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | D - M-Exempt | Non-Qualifed Stock Option (right to buy) | 6371 | 56.12 |
2022-10-19 | Gregg Vicky B | director | A - L-Small | Common Stock | 74 | 127.667 |
2022-10-03 | RING TIMOTHY M | director | A - M-Exempt | Common Stock | 2000 | 61.225 |
2022-10-03 | RING TIMOTHY M | director | D - S-Sale | Common Stock | 2000 | 123.39 |
2022-10-03 | RING TIMOTHY M | director | A - A-Award | Phantom Stock Units | 333 | 0 |
2022-10-03 | RING TIMOTHY M | director | D - M-Exempt | Stock Options (Right to Buy) | 2000 | 61.225 |
2022-09-01 | RING TIMOTHY M | director | A - M-Exempt | Common Stock | 2000 | 61.225 |
2022-09-01 | RING TIMOTHY M | D - S-Sale | Common Stock | 2000 | 125.02 | |
2022-09-01 | RING TIMOTHY M | D - M-Exempt | Stock Options (Right to Buy) | 2000 | 61.225 | |
2022-08-01 | RING TIMOTHY M | director | A - M-Exempt | Common Stock | 1851 | 61.225 |
2022-08-01 | RING TIMOTHY M | director | A - M-Exempt | Common Stock | 149 | 56.25 |
2022-08-01 | RING TIMOTHY M | D - S-Sale | Common Stock | 2000 | 136.04 | |
2022-08-01 | RING TIMOTHY M | director | D - M-Exempt | Stock Options (Right to Buy) | 1851 | 61.225 |
2022-08-01 | RING TIMOTHY M | D - M-Exempt | Stock Options (Right to Buy) | 149 | 56.25 | |
2022-07-25 | SAMAD SAM | Executive Vice President & CFO | D - | Common Stock | 0 | 0 |
2022-07-25 | SAMAD SAM | Executive Vice President & CFO | D - | Non-Qualifed Stock Option (right to buy) | 19658 | 135.585 |
2022-07-20 | Gregg Vicky B | A - L-Small | Common Stock | 70 | 134.4667 | |
2022-07-01 | RING TIMOTHY M | director | A - M-Exempt | Common Stock | 990 | 58.685 |
2022-07-01 | RING TIMOTHY M | director | A - M-Exempt | Common Stock | 1010 | 56.25 |
2022-07-01 | RING TIMOTHY M | D - S-Sale | Common Stock | 2000 | 133.47 | |
2022-07-01 | RING TIMOTHY M | director | A - A-Award | Phantom Stock Units | 308 | 0 |
2022-07-01 | RING TIMOTHY M | A - A-Award | Phantom Stock Units | 308 | 134.735 | |
2022-07-01 | RING TIMOTHY M | director | D - M-Exempt | Stock Options (Right to Buy) | 1010 | 56.25 |
2022-07-01 | RING TIMOTHY M | D - M-Exempt | Stock Options (Right to Buy) | 990 | 58.685 | |
2022-05-25 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | A - M-Exempt | Common Stock | 14854 | 86.63 |
2022-05-25 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | A - M-Exempt | Common Stock | 10037 | 103.57 |
2022-05-25 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - S-Sale | Common Stock | 9823 | 140.581 |
2022-05-25 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - S-Sale | Common Stock | 6821 | 140.602 |
2022-05-25 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - S-Sale | Common Stock | 4131 | 141.348 |
2022-05-25 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - S-Sale | Common Stock | 2565 | 141.361 |
2022-05-25 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - S-Sale | Common Stock | 900 | 142.134 |
2022-05-25 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - S-Sale | Common Stock | 651 | 142.151 |
2022-05-25 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - M-Exempt | Non-Qualifed Stock Option (right to buy) | 10037 | 103.57 |
2022-05-25 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - M-Exempt | Non-Qualifed Stock Option (right to buy) | 14854 | 86.63 |
2022-05-24 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | A - M-Exempt | Common Stock | 156282 | 86.63 |
2022-05-23 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | A - M-Exempt | Common Stock | 126126 | 103.57 |
2022-05-23 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | A - M-Exempt | Common Stock | 42568 | 86.63 |
2022-05-23 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | A - M-Exempt | Common Stock | 34898 | 103.57 |
2022-05-23 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - S-Sale | Common Stock | 41268 | 140.119 |
2022-05-23 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - S-Sale | Common Stock | 33898 | 140.124 |
2022-05-23 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - S-Sale | Common Stock | 1000 | 141.509 |
2022-05-23 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - S-Sale | Common Stock | 800 | 141.542 |
2022-05-23 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - S-Sale | Common Stock | 300 | 142.24 |
2022-05-23 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - S-Sale | Common Stock | 200 | 142.255 |
2022-05-24 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - S-Sale | Common Stock | 126126 | 140.12 |
2022-05-24 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - S-Sale | Common Stock | 156282 | 140.122 |
2022-05-23 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - M-Exempt | Non-Qualifed Stock Option (right to buy) | 42568 | 86.63 |
2022-05-23 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - M-Exempt | Non-Qualifed Stock Option (right to buy) | 34898 | 103.57 |
2022-05-24 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - M-Exempt | Non-Qualifed Stock Option (right to buy) | 156282 | 86.63 |
2022-05-24 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - M-Exempt | Non-Qualifed Stock Option (right to buy) | 126126 | 103.57 |
2022-05-18 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | D - F-InKind | Common Stock | 8 | 136.98 |
2022-05-18 | WILENSKY GAIL R | A - A-Award | Common Stock | 1292 | 0 | |
2022-05-18 | Doi Tracey | A - A-Award | Common Stock | 1292 | 0 | |
2022-05-18 | RING TIMOTHY M | A - A-Award | Common Stock | 1292 | 0 | |
2022-05-18 | PFEIFFER GARY M | A - A-Award | Common Stock | 1292 | 0 | |
2022-05-18 | MAIN TIMOTHY L | A - A-Award | Common Stock | 1292 | 0 | |
2022-04-18 | Gregg Vicky B | A - A-Award | Common Stock | 1292 | 0 | |
2022-04-18 | Gregg Vicky B | A - L-Small | Common Stock | 61 | 134.88 | |
2022-05-18 | MORRISON DENISE M | A - A-Award | Common Stock | 1292 | 0 | |
2022-05-18 | Lassiter Wright III | A - A-Award | Common Stock | 1292 | 0 | |
2022-05-17 | PREVOZNIK MICHAEL E | SVP & General Counsel | A - M-Exempt | Common Stock | 50604 | 66.51 |
2022-05-17 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - S-Sale | Common Stock | 50604 | 139.969 |
2022-05-17 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - M-Exempt | Non-Qualifed Stock Option (right to buy) | 50604 | 66.51 |
2022-04-01 | RING TIMOTHY M | director | A - A-Award | Phantom Stock Units | 306 | 0 |
2022-04-01 | RING TIMOTHY M | A - A-Award | Phantom Stock Units | 306 | 135.445 | |
2022-03-07 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | A - A-Award | Common Stock | 2310 | 130.09 |
2022-03-07 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | D - F-InKind | Common Stock | 79 | 130.09 |
2022-03-07 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | A - A-Award | Common Stock | 70184 | 130.09 |
2022-03-07 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - F-InKind | Common Stock | 32570 | 130.09 |
2022-03-07 | PREVOZNIK MICHAEL E | SVP & General Counsel | A - A-Award | Common Stock | 11544 | 130.09 |
2022-03-07 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - F-InKind | Common Stock | 5316 | 130.09 |
2022-03-07 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - S-Sale | Common Stock | 6228 | 135.21 |
2022-03-07 | GUINAN MARK | Executive Vice President & CFO | A - A-Award | Common Stock | 20780 | 130.09 |
2022-03-07 | GUINAN MARK | Executive Vice President & CFO | D - F-InKind | Common Stock | 10475 | 130.09 |
2022-03-07 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | A - A-Award | Common Stock | 16162 | 130.09 |
2022-03-07 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | D - F-InKind | Common Stock | 7947 | 130.09 |
2022-03-07 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | A - A-Award | Common Stock | 13392 | 130.09 |
2022-03-07 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | D - F-InKind | Common Stock | 6360 | 130.09 |
2022-03-07 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | D - S-Sale | Common Stock | 7032 | 135.21 |
2022-03-07 | Davis J. E. | EVP-Gen. Diagnostics/CEO Elect | A - A-Award | Common Stock | 19856 | 130.09 |
2022-03-07 | Davis J. E. | EVP-Gen. Diagnostics/CEO Elect | D - F-InKind | Common Stock | 10330 | 130.09 |
2022-02-28 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - S-Sale | Common Stock | 661 | 130 |
2022-02-24 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | A - A-Award | Common Stock | 22510 | 0 |
2022-02-24 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | A - A-Award | Non-Qualifed Stock Option (right to buy) | 109317 | 127.725 |
2022-02-24 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | A - A-Award | Common Stock | 3328 | 0 |
2022-02-24 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | D - S-Sale | Common Stock | 2750 | 126.26 |
2022-02-24 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | A - A-Award | Non-Qualifed Stock Option (right to buy) | 16155 | 127.725 |
2022-02-24 | Davis J. E. | EVP-Gen. Diagnostics/CEO Elect | A - A-Award | Common Stock | 9787 | 0 |
2022-02-24 | Davis J. E. | EVP-Gen. Diagnostics/CEO Elect | A - A-Award | Non-Qualifed Stock Option (right to buy) | 47529 | 127.725 |
2022-02-24 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | A - A-Award | Common Stock | 3132 | 0 |
2022-02-24 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | A - A-Award | Common Stock | 549 | 0 |
2022-02-24 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | A - A-Award | Non-Qualifed Stock Option (right to buy) | 2654 | 127.725 |
2022-02-24 | GUINAN MARK | Executive Vice President & CFO | A - A-Award | Common Stock | 2251 | 0 |
2022-02-24 | GUINAN MARK | Executive Vice President & CFO | A - A-Award | Non-Qualifed Stock Option (right to buy) | 10932 | 127.725 |
2022-02-24 | PREVOZNIK MICHAEL E | SVP & General Counsel | A - A-Award | Common Stock | 2741 | 0 |
2022-02-24 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - S-Sale | Common Stock | 1669 | 126.26 |
2022-02-24 | PREVOZNIK MICHAEL E | SVP & General Counsel | A - A-Award | Non-Qualifed Stock Option (right to buy) | 13301 | 127.725 |
2022-02-24 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | A - A-Award | Common Stock | 7830 | 0 |
2022-02-24 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | A - A-Award | Common Stock | 3915 | 0 |
2022-02-24 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | A - A-Award | Non-Qualifed Stock Option (right to buy) | 19009 | 127.725 |
2022-02-23 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - F-InKind | Common Stock | 7463 | 130.09 |
2022-02-23 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - F-InKind | Common Stock | 2255 | 130.23 |
2022-02-23 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - F-InKind | Common Stock | 933 | 130.09 |
2022-02-23 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - F-InKind | Common Stock | 406 | 130.23 |
2022-02-23 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | D - F-InKind | Common Stock | 94 | 130.23 |
2022-02-23 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | D - F-InKind | Common Stock | 219 | 130.09 |
2022-02-23 | GUINAN MARK | Executive Vice President & CFO | D - F-InKind | Common Stock | 1673 | 130.09 |
2022-02-23 | GUINAN MARK | Executive Vice President & CFO | D - F-InKind | Common Stock | 694 | 130.23 |
2022-02-23 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | D - F-InKind | Common Stock | 1082 | 130.09 |
2022-02-23 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | D - F-InKind | Common Stock | 492 | 130.23 |
2022-02-23 | Davis J. E. | EVP-Gen. Diagnostics/CEO Elect | D - F-InKind | Common Stock | 1712 | 130.09 |
2022-02-23 | Davis J. E. | EVP-Gen. Diagnostics/CEO Elect | D - F-InKind | Common Stock | 724 | 130.23 |
2022-02-23 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | D - F-InKind | Common Stock | 1368 | 130.09 |
2022-02-23 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | D - F-InKind | Common Stock | 609 | 130.23 |
2022-01-03 | RING TIMOTHY M | director | A - A-Award | Phantom Stock Units | 247 | 0 |
2021-11-29 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | A - M-Exempt | Common Stock | 37565 | 95.795 |
2021-11-29 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | D - S-Sale | Common Stock | 300 | 153.383 |
2021-11-29 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | D - S-Sale | Common Stock | 3250 | 154.792 |
2021-11-29 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | D - S-Sale | Common Stock | 3532 | 155.774 |
2021-11-29 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | D - S-Sale | Common Stock | 15908 | 156.855 |
2021-11-29 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | D - S-Sale | Common Stock | 14575 | 157.533 |
2021-11-29 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | D - M-Exempt | Non-Qualifed Stock Option (right to buy) | 37565 | 95.795 |
2021-10-01 | RING TIMOTHY M | director | A - A-Award | Phantom Stock Units | 288 | 0 |
2021-08-16 | Doi Tracey | director | A - A-Award | Common Stock | 905 | 0 |
2021-08-16 | Doi Tracey | - | 0 | 0 | ||
2021-07-28 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | A - M-Exempt | Common Stock | 139751 | 95.795 |
2021-07-29 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | A - M-Exempt | Common Stock | 5300 | 95.795 |
2021-07-29 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | A - M-Exempt | Common Stock | 4193 | 95.795 |
2021-07-29 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - S-Sale | Common Stock | 4193 | 141.216 |
2021-07-28 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - S-Sale | Common Stock | 139751 | 140.141 |
2021-07-29 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - S-Sale | Common Stock | 5300 | 140.591 |
2021-07-28 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - M-Exempt | Non-Qualifed Stock Option (right to buy) | 139751 | 95.795 |
2021-07-29 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - M-Exempt | Non-Qualifed Stock Option (right to buy) | 5300 | 95.795 |
2021-07-29 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - M-Exempt | Non-Qualifed Stock Option (right to buy) | 4193 | 95.795 |
2021-07-27 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | A - M-Exempt | Common Stock | 32788 | 95.795 |
2021-07-26 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | A - M-Exempt | Common Stock | 5813 | 95.795 |
2021-07-26 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - S-Sale | Common Stock | 5813 | 140.03 |
2021-07-27 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - S-Sale | Common Stock | 32788 | 140.007 |
2021-07-26 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - M-Exempt | Non-Qualifed Stock Option (right to buy) | 5813 | 95.795 |
2021-07-27 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - M-Exempt | Non-Qualifed Stock Option (right to buy) | 32788 | 95.795 |
2021-07-27 | WILENSKY GAIL R | director | A - M-Exempt | Common Stock | 6111 | 57.565 |
2021-07-27 | WILENSKY GAIL R | director | A - M-Exempt | Common Stock | 6111 | 61.225 |
2021-07-27 | WILENSKY GAIL R | director | D - S-Sale | Common Stock | 6111 | 139.323 |
2021-07-27 | WILENSKY GAIL R | director | D - S-Sale | Common Stock | 6111 | 139.268 |
2021-07-27 | WILENSKY GAIL R | director | D - M-Exempt | Stock Options (Right to Buy) | 6111 | 57.565 |
2021-07-27 | WILENSKY GAIL R | director | D - M-Exempt | Stock Options (Right to Buy) | 6111 | 61.225 |
2021-07-01 | RING TIMOTHY M | director | A - A-Award | Phantom Stock Units | 313 | 0 |
2021-05-25 | PFEIFFER GARY M | director | A - A-Award | Common Stock | 1363 | 0 |
2021-05-25 | RING TIMOTHY M | director | A - A-Award | Common Stock | 1363 | 0 |
2021-05-25 | WILENSKY GAIL R | director | A - A-Award | Common Stock | 1363 | 0 |
2021-05-25 | Lassiter Wright III | director | A - A-Award | Common Stock | 1363 | 0 |
2021-05-25 | MAIN TIMOTHY L | director | A - A-Award | Common Stock | 1363 | 0 |
2021-05-25 | Torley Helen | director | A - A-Award | Common Stock | 1363 | 0 |
2021-05-21 | Gregg Vicky B | director | A - A-Award | Common Stock | 1363 | 0 |
2021-05-25 | MORRISON DENISE M | director | A - A-Award | Common Stock | 1363 | 0 |
2021-05-18 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | D - F-InKind | Common Stock | 5 | 136.6 |
2021-05-07 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | D - S-Sale | Common Stock | 8536 | 139.963 |
2021-05-05 | PREVOZNIK MICHAEL E | SVP & General Counsel | A - M-Exempt | Common Stock | 44939 | 71.17 |
2021-05-05 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - S-Sale | Common Stock | 44939 | 137 |
2021-05-05 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - M-Exempt | Non-Qualifed Stock Option (right to buy) | 44939 | 71.17 |
2021-04-01 | RING TIMOTHY M | director | A - A-Award | Phantom Stock Units | 325.79 | 0 |
2021-03-09 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | A - A-Award | Common Stock | 58368 | 115.42 |
2021-03-09 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - F-InKind | Common Stock | 25887 | 115.42 |
2021-03-09 | PREVOZNIK MICHAEL E | SVP & General Counsel | A - A-Award | Common Stock | 9791 | 115.42 |
2021-03-09 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - F-InKind | Common Stock | 4217 | 115.42 |
2021-03-10 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - S-Sale | Common Stock | 5574 | 120.47 |
2021-03-09 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | A - A-Award | Common Stock | 1884 | 115.42 |
2021-03-09 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | D - F-InKind | Common Stock | 684 | 115.42 |
2021-03-09 | GUINAN MARK | Executive Vice President & CFO | A - A-Award | Common Stock | 17322 | 115.42 |
2021-03-09 | GUINAN MARK | Executive Vice President & CFO | D - F-InKind | Common Stock | 6403 | 115.42 |
2021-03-09 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | A - A-Award | Common Stock | 11299 | 115.42 |
2021-03-09 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | D - F-InKind | Common Stock | 5066 | 115.42 |
2021-03-09 | Davis J. E. | EVP, General Diagnostics | A - A-Award | Common Stock | 16570 | 115.42 |
2021-03-09 | Davis J. E. | EVP, General Diagnostics | D - F-InKind | Common Stock | 8334 | 115.42 |
2021-03-09 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | A - A-Award | Common Stock | 13181 | 115.42 |
2021-03-09 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | D - F-InKind | Common Stock | 6165 | 115.42 |
2021-02-25 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - S-Sale | Common Stock | 801 | 115.49 |
2021-02-23 | Davis J. E. | EVP, General Diagnostics | D - F-InKind | Common Stock | 1250 | 121.15 |
2021-02-24 | Davis J. E. | EVP, General Diagnostics | D - F-InKind | Common Stock | 806 | 121.19 |
2021-02-23 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - F-InKind | Common Stock | 693 | 121.15 |
2021-02-24 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - F-InKind | Common Stock | 455 | 121.19 |
2021-02-24 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - S-Sale | Common Stock | 438 | 116.95 |
2021-02-24 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - S-Sale | Common Stock | 750 | 116.95 |
2021-02-23 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | D - F-InKind | Common Stock | 159 | 121.15 |
2021-02-24 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | D - F-InKind | Common Stock | 103 | 121.19 |
2021-02-23 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | D - F-InKind | Common Stock | 1017 | 121.15 |
2021-02-24 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | D - F-InKind | Common Stock | 611 | 121.19 |
2021-02-23 | GUINAN MARK | Executive Vice President & CFO | D - F-InKind | Common Stock | 830 | 121.15 |
2021-02-24 | GUINAN MARK | Executive Vice President & CFO | D - F-InKind | Common Stock | 541 | 121.19 |
2021-02-23 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - F-InKind | Common Stock | 4033 | 121.15 |
2021-02-24 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - F-InKind | Common Stock | 3319 | 121.19 |
2021-02-23 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | D - F-InKind | Common Stock | 796 | 121.15 |
2021-02-24 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | D - F-InKind | Common Stock | 524 | 121.19 |
2021-02-17 | Mendez Manuel O. | SVP & Chief Commercial Officer | A - A-Award | Common Stock | 4926 | 0 |
2021-02-17 | Mendez Manuel O. | SVP & Chief Commercial Officer | A - A-Award | Non-Qualifed Stock Option (right to buy) | 27633 | 121.805 |
2021-02-17 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | A - A-Award | Common Stock | 21551 | 0 |
2021-02-17 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | A - A-Award | Non-Qualifed Stock Option (right to buy) | 120901 | 121.805 |
2021-02-17 | PREVOZNIK MICHAEL E | SVP & General Counsel | A - A-Award | Common Stock | 3202 | 0 |
2021-02-17 | PREVOZNIK MICHAEL E | SVP & General Counsel | A - A-Award | Non-Qualifed Stock Option (right to buy) | 17958 | 121.805 |
2021-02-17 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | A - A-Award | Common Stock | 715 | 0 |
2021-02-17 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | A - A-Award | Non-Qualifed Stock Option (right to buy) | 4003 | 121.805 |
2021-02-17 | GUINAN MARK | Executive Vice President & CFO | A - A-Award | Common Stock | 5665 | 0 |
2021-02-17 | GUINAN MARK | Executive Vice President & CFO | A - A-Award | Non-Qualifed Stock Option (right to buy) | 31774 | 121.805 |
2021-02-17 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | A - A-Award | Common Stock | 3941 | 0 |
2021-02-17 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | A - A-Award | Non-Qualifed Stock Option (right to buy) | 22105 | 121.805 |
2021-02-17 | Davis J. E. | EVP, General Diagnostics | A - A-Award | Common Stock | 5665 | 0 |
2021-02-17 | Davis J. E. | EVP, General Diagnostics | A - A-Award | Non-Qualifed Stock Option (right to buy) | 31774 | 121.805 |
2021-02-17 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | A - A-Award | Non-Qualifed Stock Option (right to buy) | 27633 | 121.805 |
2021-02-17 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | A - A-Award | Common Stock | 4926 | 0 |
2021-01-04 | RING TIMOTHY M | director | A - A-Award | Phantom Stock Units | 264 | 0 |
2021-01-04 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | D - F-InKind | Common Stock | 2640 | 119 |
2020-12-24 | GUINAN MARK | Executive Vice President & CFO | A - M-Exempt | Common Stock | 81756 | 66.51 |
2020-12-24 | GUINAN MARK | Executive Vice President & CFO | D - S-Sale | Common Stock | 59193 | 120.057 |
2020-12-24 | GUINAN MARK | Executive Vice President & CFO | D - S-Sale | Common Stock | 22563 | 121.178 |
2020-12-24 | GUINAN MARK | Executive Vice President & CFO | D - M-Exempt | Non-Qualifed Stock Option (right to buy) | 81756 | 66.51 |
2020-11-24 | WILENSKY GAIL R | director | A - M-Exempt | Common Stock | 6111 | 57.665 |
2020-11-24 | WILENSKY GAIL R | director | D - S-Sale | Common Stock | 6111 | 126.022 |
2020-11-24 | WILENSKY GAIL R | director | D - M-Exempt | Stock Options (Right to Buy) | 6111 | 57.665 |
2020-11-23 | STANZIONE DANIEL | director | D - S-Sale | Common Stock | 5621 | 125.7317 |
2020-11-23 | STANZIONE DANIEL | director | D - S-Sale | Common Stock | 3302 | 126.4639 |
2020-11-23 | STANZIONE DANIEL | director | D - S-Sale | Common Stock | 2300 | 127.4508 |
2020-10-21 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | A - M-Exempt | Common Stock | 5700 | 57.605 |
2020-10-21 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | A - M-Exempt | Common Stock | 4750 | 56.82 |
2020-10-21 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | D - S-Sale | Common Stock | 5700 | 125 |
2020-10-21 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | D - S-Sale | Common Stock | 4750 | 125 |
2020-10-21 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | D - M-Exempt | Non-Qualifed Stock Option (right to buy) | 4750 | 56.82 |
2020-10-21 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | D - M-Exempt | Non-Qualifed Stock Option (right to buy) | 5700 | 57.605 |
2020-10-16 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | A - M-Exempt | Common Stock | 291997 | 66.51 |
2020-10-16 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - S-Sale | Common Stock | 291997 | 120 |
2020-10-16 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - M-Exempt | Non-Qualifed Stock Option (right to buy) | 291997 | 66.51 |
2020-10-14 | PREVOZNIK MICHAEL E | SVP & General Counsel | A - M-Exempt | Common Stock | 35591 | 52.165 |
2020-10-14 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - S-Sale | Common Stock | 35591 | 119 |
2020-10-14 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - M-Exempt | Stock Options (Right to Buy) | 35591 | 52.165 |
2020-10-06 | Mendez Manuel O. | SVP & Chief Commercial Officer | D - F-InKind | Common Stock | 5871 | 114.01 |
2020-10-01 | RING TIMOTHY M | director | A - A-Award | Phantom Stock Units | 270 | 0 |
2020-09-02 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | A - M-Exempt | Common Stock | 58392 | 66.51 |
2020-09-02 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | D - S-Sale | Common Stock | 54616 | 110.567 |
2020-09-02 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | D - S-Sale | Common Stock | 3776 | 111.127 |
2020-09-02 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | D - M-Exempt | Non-Qualifed Stock Option (right to buy) | 58392 | 66.51 |
2020-07-01 | RING TIMOTHY M | director | A - A-Award | Phantom Stock Units | 203 | 0 |
2020-06-08 | GUINAN MARK | Executive Vice President & CFO | A - M-Exempt | Common Stock | 72596 | 71.17 |
2020-06-08 | GUINAN MARK | Executive Vice President & CFO | D - S-Sale | Common Stock | 45826 | 116.811 |
2020-06-08 | GUINAN MARK | Executive Vice President & CFO | D - S-Sale | Common Stock | 18246 | 117.649 |
2020-06-08 | GUINAN MARK | Executive Vice President & CFO | D - S-Sale | Common Stock | 8524 | 118.604 |
2020-06-08 | GUINAN MARK | Executive Vice President & CFO | D - M-Exempt | Non-Qualifed Stock Option (right to buy) | 72596 | 71.17 |
2020-06-08 | RING TIMOTHY M | director | A - M-Exempt | Common Stock | 779 | 63.42 |
2020-06-08 | RING TIMOTHY M | director | A - M-Exempt | Common Stock | 790 | 60.215 |
2020-06-08 | RING TIMOTHY M | director | A - M-Exempt | Common Stock | 6111 | 57.565 |
2020-06-08 | RING TIMOTHY M | director | A - M-Exempt | Common Stock | 820 | 61.615 |
2020-06-08 | RING TIMOTHY M | director | A - M-Exempt | Common Stock | 151 | 58.37 |
2020-06-08 | RING TIMOTHY M | director | A - M-Exempt | Common Stock | 532 | 58.37 |
2020-06-08 | RING TIMOTHY M | director | A - M-Exempt | Common Stock | 2547 | 57.74 |
2020-06-08 | RING TIMOTHY M | director | D - S-Sale | Common Stock | 11730 | 116.6 |
2020-06-08 | RING TIMOTHY M | director | D - M-Exempt | Stock Options (Right to Buy) | 790 | 60.215 |
2020-06-08 | RING TIMOTHY M | director | D - M-Exempt | Stock Options (Right to Buy) | 779 | 63.42 |
2020-06-08 | RING TIMOTHY M | director | D - M-Exempt | Stock Options (Right to Buy) | 2547 | 57.74 |
2020-06-08 | RING TIMOTHY M | director | D - M-Exempt | Stock Options (Right to Buy) | 532 | 58.37 |
2020-06-08 | RING TIMOTHY M | director | D - M-Exempt | Non-Qualifed Stock Option (right to buy) | 151 | 58.37 |
2020-06-08 | RING TIMOTHY M | director | D - M-Exempt | Stock Options (Right to Buy) | 820 | 61.615 |
2020-06-08 | RING TIMOTHY M | director | D - M-Exempt | Stock Options (Right to Buy) | 6111 | 57.565 |
2020-05-19 | Lassiter Wright III | director | A - A-Award | Common Stock | 1531 | 0 |
2020-05-19 | WILENSKY GAIL R | director | A - A-Award | Common Stock | 1531 | 0 |
2020-05-19 | STANZIONE DANIEL | director | A - A-Award | Common Stock | 1531 | 0 |
2020-05-19 | RING TIMOTHY M | director | A - A-Award | Common Stock | 1531 | 0 |
2020-05-19 | PFEIFFER GARY M | director | A - A-Award | Common Stock | 1531 | 0 |
2020-05-19 | MAIN TIMOTHY L | director | A - A-Award | Common Stock | 1531 | 0 |
2020-05-19 | Torley Helen | director | A - A-Award | Common Stock | 1531 | 0 |
2020-05-19 | Gregg Vicky B | director | A - A-Award | Common Stock | 1531 | 0 |
2020-05-19 | MORRISON DENISE M | director | A - A-Award | Common Stock | 1531 | 0 |
2020-05-18 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | D - F-InKind | Common Stock | 5 | 107.42 |
2020-04-27 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | A - M-Exempt | Common Stock | 11717 | 71.17 |
2020-04-27 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - S-Sale | Common Stock | 11717 | 112.011 |
2020-04-27 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - M-Exempt | Non-Qualifed Stock Option (right to buy) | 11717 | 71.17 |
2020-04-27 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | D - S-Sale | Common Stock | 2500 | 112.03 |
2020-04-27 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | D - S-Sale | Common Stock | 2500 | 110 |
2020-04-01 | RING TIMOTHY M | director | A - A-Award | Phantom Stock Units | 403 | 0 |
2020-03-16 | Davis J. E. | EVP, General Diagnostics | D - S-Sale | Common Stock | 200 | 85.59 |
2020-03-16 | Davis J. E. | EVP, General Diagnostics | D - S-Sale | Common Stock | 1085 | 86.654 |
2020-03-16 | Davis J. E. | EVP, General Diagnostics | D - S-Sale | Common Stock | 1307 | 87.813 |
2020-03-16 | Davis J. E. | EVP, General Diagnostics | D - S-Sale | Common Stock | 421 | 88.525 |
2020-03-16 | Davis J. E. | EVP, General Diagnostics | D - S-Sale | Common Stock | 500 | 90.146 |
2020-03-12 | Lassiter Wright III | director | A - A-Award | Common Stock | 351 | 0 |
2020-03-12 | Lassiter Wright III | - | 0 | 0 | ||
2020-03-10 | Davis J. E. | EVP, General Diagnostics | A - A-Award | Common Stock | 7359 | 106.46 |
2020-03-10 | Davis J. E. | EVP, General Diagnostics | D - F-InKind | Common Stock | 3846 | 106.46 |
2020-03-10 | PREVOZNIK MICHAEL E | SVP & General Counsel | A - A-Award | Common Stock | 4349 | 106.46 |
2020-03-10 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - F-InKind | Common Stock | 2174 | 106.46 |
2020-03-11 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - S-Sale | Common Stock | 2175 | 104.25 |
2020-03-10 | GUINAN MARK | Executive Vice President & CFO | A - A-Award | Common Stock | 7693 | 106.46 |
2020-03-10 | GUINAN MARK | Executive Vice President & CFO | D - F-InKind | Common Stock | 3870 | 106.46 |
2020-03-10 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | A - A-Award | Common Stock | 5018 | 106.46 |
2020-03-10 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | D - F-InKind | Common Stock | 2517 | 106.46 |
2020-03-11 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | D - S-Sale | Common Stock | 2501 | 104.25 |
2020-03-10 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | A - A-Award | Common Stock | 25085 | 106.46 |
2020-03-10 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | A - M-Exempt | Common Stock | 100 | 71.17 |
2020-03-10 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - F-InKind | Common Stock | 13898 | 106.46 |
2020-03-10 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - S-Sale | Common Stock | 100 | 112.19 |
2020-03-10 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - M-Exempt | Non-Qualifed Stock Option (right to buy) | 100 | 71.17 |
2020-03-10 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | A - A-Award | Common Stock | 837 | 106.46 |
2020-03-10 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | D - F-InKind | Common Stock | 277 | 106.46 |
2020-03-10 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | A - A-Award | Common Stock | 5018 | 106.46 |
2020-03-10 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | D - F-InKind | Common Stock | 2517 | 106.46 |
2020-03-06 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | A - M-Exempt | Common Stock | 230178 | 71.17 |
2020-03-06 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - S-Sale | Common Stock | 171025 | 112.207 |
2020-03-06 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - S-Sale | Common Stock | 36790 | 113.652 |
2020-03-06 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - S-Sale | Common Stock | 16426 | 114.236 |
2020-03-06 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - S-Sale | Common Stock | 3937 | 115.452 |
2020-03-06 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - S-Sale | Common Stock | 2000 | 116.272 |
2020-03-06 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - M-Exempt | Non-Qualifed Stock Option (right to buy) | 230178 | 71.17 |
2020-02-26 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - S-Sale | Common Stock | 321 | 111.09 |
2020-02-26 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - F-InKind | Common Stock | 668 | 112.9 |
2020-02-27 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - S-Sale | Common Stock | 690 | 109.02 |
2020-02-26 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | D - S-Sale | Common Stock | 368 | 111.09 |
2020-02-26 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | D - F-InKind | Common Stock | 777 | 112.9 |
2020-02-27 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | D - S-Sale | Common Stock | 789 | 109.02 |
2020-02-26 | Davis J. E. | EVP, General Diagnostics | D - S-Sale | Common Stock | 510 | 111.09 |
2020-02-26 | Davis J. E. | EVP, General Diagnostics | D - F-InKind | Common Stock | 1187 | 112.9 |
2020-02-27 | Davis J. E. | EVP, General Diagnostics | D - S-Sale | Common Stock | 1100 | 109.02 |
2020-02-26 | GUINAN MARK | Executive Vice President & CFO | D - F-InKind | Common Stock | 1195 | 112.9 |
2020-02-26 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - F-InKind | Common Stock | 4299 | 112.9 |
2020-02-26 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | D - F-InKind | Common Stock | 773 | 112.9 |
2020-02-26 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | D - F-InKind | Common Stock | 98 | 112.9 |
2020-02-24 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | D - F-InKind | Common Stock | 56 | 112.17 |
2020-02-25 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | D - F-InKind | Common Stock | 49 | 113.34 |
2020-02-24 | Davis J. E. | EVP, General Diagnostics | D - F-InKind | Common Stock | 643 | 112.17 |
2020-02-25 | Davis J. E. | EVP, General Diagnostics | D - S-Sale | Common Stock | 598 | 112.73 |
2020-02-25 | Davis J. E. | EVP, General Diagnostics | D - F-InKind | Common Stock | 552 | 113.34 |
2020-02-24 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - F-InKind | Common Stock | 382 | 112.17 |
2020-02-25 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - F-InKind | Common Stock | 307 | 113.34 |
2020-02-24 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | D - F-InKind | Common Stock | 515 | 112.17 |
2020-02-25 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | D - F-InKind | Common Stock | 423 | 113.34 |
2020-02-24 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - F-InKind | Common Stock | 2404 | 112.17 |
2020-02-25 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | D - F-InKind | Common Stock | 2074 | 113.34 |
2020-02-24 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | D - F-InKind | Common Stock | 432 | 112.17 |
2020-02-25 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | D - S-Sale | Common Stock | 405 | 112.73 |
2020-02-25 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | D - F-InKind | Common Stock | 356 | 113.34 |
2020-02-24 | Mendez Manuel O. | SVP & Chief Commercial Officer | D - F-InKind | Common Stock | 123 | 112.17 |
2020-02-24 | GUINAN MARK | Executive Vice President & CFO | D - F-InKind | Common Stock | 653 | 112.17 |
2020-02-25 | GUINAN MARK | Executive Vice President & CFO | D - F-InKind | Common Stock | 565 | 113.34 |
2020-02-18 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | A - A-Award | Common Stock | 776 | 0 |
2020-02-18 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | A - A-Award | Non-Qualifed Stock Option (right to buy) | 5059 | 112.17 |
2020-02-18 | RUSCKOWSKI STEPHEN H | Chairman, President and CEO | A - A-Award | Common Stock | 22288 | 0 |
2020-02-18 | RUSCKOWSKI STEPHEN H | Chairman, President and CEO | A - A-Award | Non-Qualifed Stock Option (right to buy) | 145361 | 112.17 |
2020-02-18 | PREVOZNIK MICHAEL E | SVP & General Counsel | A - A-Award | Common Stock | 3477 | 0 |
2020-02-18 | PREVOZNIK MICHAEL E | SVP & General Counsel | A - A-Award | Non-Qualifed Stock Option (right to buy) | 22677 | 112.17 |
2020-02-18 | Davis J. E. | EVP, General Diagnostics | A - A-Award | Common Stock | 6152 | 0 |
2020-02-18 | Davis J. E. | EVP, General Diagnostics | A - A-Award | Non-Qualifed Stock Option (right to buy) | 40120 | 112.17 |
2020-02-18 | Mendez Manuel O. | SVP & Chief Commercial Officer | A - A-Award | Non-Qualifed Stock Option (right to buy) | 34887 | 112.17 |
2020-02-18 | Mendez Manuel O. | SVP & Chief Commercial Officer | A - A-Award | Common Stock | 5350 | 0 |
2020-02-18 | GUINAN MARK | Executive Vice President & CFO | A - A-Award | Common Stock | 6152 | 0 |
2020-02-18 | GUINAN MARK | Executive Vice President & CFO | A - A-Award | Non-Qualifed Stock Option (right to buy) | 40120 | 112.17 |
2020-02-18 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | A - A-Award | Common Stock | 4012 | 0 |
2020-02-18 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | A - A-Award | Non-Qualifed Stock Option (right to buy) | 26165 | 112.17 |
2020-02-18 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | A - A-Award | Non-Qualifed Stock Option (right to buy) | 34887 | 112.17 |
2020-02-18 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | A - A-Award | Common Stock | 5350 | 0 |
2020-02-07 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - G-Gift | Common Stock | 480 | 0 |
2020-01-02 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | D - F-InKind | Common Stock | 1543 | 106.52 |
2020-01-02 | RING TIMOTHY M | director | A - A-Award | Phantom Stock Units | 291 | 0 |
2020-01-02 | Davis J. E. | EVP, General Diagnostics | A - M-Exempt | Common Stock | 77865 | 66.51 |
2020-01-02 | Davis J. E. | EVP, General Diagnostics | D - S-Sale | Common Stock | 58258 | 105.458 |
2020-01-02 | Davis J. E. | EVP, General Diagnostics | D - S-Sale | Common Stock | 7423 | 106.513 |
2020-01-02 | Davis J. E. | EVP, General Diagnostics | A - M-Exempt | Common Stock | 65681 | 71.17 |
2020-01-02 | Davis J. E. | EVP, General Diagnostics | D - S-Sale | Common Stock | 69003 | 105.452 |
2020-01-02 | Davis J. E. | EVP, General Diagnostics | D - S-Sale | Common Stock | 8853 | 106.511 |
2020-01-02 | Davis J. E. | EVP, General Diagnostics | D - M-Exempt | Non-Qualifed Stock Option (right to buy) | 65681 | 71.17 |
2020-01-02 | Davis J. E. | EVP, General Diagnostics | D - M-Exempt | Non-Qualifed Stock Option (right to buy) | 77865 | 66.51 |
2019-11-27 | PREVOZNIK MICHAEL E | SVP & General Counsel | A - M-Exempt | Common Stock | 32693 | 56.12 |
2019-11-27 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - S-Sale | Common Stock | 11863 | 107.148 |
2019-11-27 | PREVOZNIK MICHAEL E | SVP & General Counsel | A - M-Exempt | Common Stock | 11863 | 52.165 |
2019-11-27 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - S-Sale | Common Stock | 32193 | 107.525 |
2019-11-27 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - S-Sale | Common Stock | 500 | 107.83 |
2019-11-27 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - M-Exempt | Stock Options (Right to Buy) | 11863 | 52.165 |
2019-11-27 | PREVOZNIK MICHAEL E | SVP & General Counsel | D - M-Exempt | Stock Options (Right to Buy) | 32693 | 56.12 |
2019-11-26 | WILENSKY GAIL R | director | A - M-Exempt | Common Stock | 8000 | 55.76 |
2019-11-26 | WILENSKY GAIL R | director | D - S-Sale | Common Stock | 8000 | 107.169 |
2019-11-26 | WILENSKY GAIL R | director | D - M-Exempt | Stock Options (Right to Buy) | 8000 | 55.76 |
2019-11-19 | Mendez Manuel O. | SVP & Chief Commercial Officer | D - | Common Stock | 0 | 0 |
2019-11-19 | Mendez Manuel O. | SVP & Chief Commercial Officer | D - | Non-Qualifed Stock Option (right to buy) | 15970 | 100.39 |
2019-10-01 | RING TIMOTHY M | director | A - A-Award | Phantom Stock Units | 288 | 0 |
2019-10-01 | MORRISON DENISE M | director | A - A-Award | Phantom Stock Units | 264 | 0 |
2019-09-17 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | A - M-Exempt | Common Stock | 5000 | 55.65 |
2019-09-17 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | D - S-Sale | Common Stock | 5000 | 106 |
2019-09-17 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | D - M-Exempt | Non-Qualifed Stock Option (right to buy) | 5000 | 55.65 |
2019-07-01 | RING TIMOTHY M | director | A - A-Award | Phantom Stock Units | 300 | 0 |
2019-07-01 | MORRISON DENISE M | director | A - A-Award | Phantom Stock Units | 275 | 0 |
2019-06-13 | RUSCKOWSKI STEPHEN H | Chairman, President and CEO | A - M-Exempt | Common Stock | 244565 | 52.165 |
2019-06-13 | RUSCKOWSKI STEPHEN H | Chairman, President and CEO | D - S-Sale | Common Stock | 244565 | 100 |
2019-06-13 | RUSCKOWSKI STEPHEN H | Chairman, President and CEO | D - M-Exempt | Stock Options (Right to Buy) | 244565 | 52.165 |
2019-06-13 | GUINAN MARK | Executive Vice President & CFO | A - M-Exempt | Common Stock | 73005 | 52.165 |
2019-06-13 | GUINAN MARK | Executive Vice President & CFO | D - S-Sale | Common Stock | 73005 | 100 |
2019-06-13 | GUINAN MARK | Executive Vice President & CFO | D - M-Exempt | Stock Options (Right to Buy) | 73005 | 52.165 |
2019-05-14 | PFEIFFER GARY M | director | A - A-Award | Common Stock | 1722 | 0 |